Jennifer S. Guimbellot, David P. Nichols, John J. Brewington. (2022) Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis. Clinics in Chest Medicine 43:4, 617-630.
Online publication date: 1-Dec-2022.
Crossref

Aduragbemi A. Faniyi, Michael J. Hughes, Aaron Scott, Kylie B. R. Belchamber, Elizabeth Sapey. (2022) Inflammation, ageing and diseases of the lung: Potential therapeutic strategies from shared biological pathways. British Journal of Pharmacology 179:9, 1790-1807.
Online publication date: 21-Jan-2022.
Crossref

Martin Donnelley, Mark Gardner, Kaye Morgan, David Parsons. 2021. Non-absorptive clearance from airways. Inhaled Medicines, 197-223.
Crossref

Maelle Briottet, Mickael Shum, Valerie Urbach. (2020) The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease. Frontiers in Pharmacology 11.
Online publication date: 2-Sep-2020.
Crossref

Ren-Jay Shei, Kelly A. Mackintosh, Jacelyn E. Peabody Lever, Melitta A. McNarry, Stefanie Krick. (2019) Exercise Physiology Across the Lifespan in Cystic Fibrosis. Frontiers in Physiology 10.
Online publication date: 5-Nov-2019.
Crossref

Burton F. Dickey. (2018) Chair’s Summary: Secreted Mucins in Lung Diseases. Annals of the American Thoracic Society 15:Supplement_3, S140-S142.
Online publication date: 15-Nov-2018.
First Page | Full Text | PDF (441 KB) | Supplemental Material